Skye Bioscience, Inc. Current Assets
Skye Bioscience, Inc. (SKYE) had Current Assets of $10.96 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $10.96M.
- 2026-03-31: Assets, Current $18.57M.
- 2025-12-31: Assets, Current $27.09M.
- 2025-09-30: Assets, Current $39.92M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $10.96M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $18.57M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $27.09M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $39.92M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $50.58M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $63.03M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $70.83M 10-K · filed 2026-03-10 |
| 2024-09-30 | $79.81M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $87.00M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $94.57M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $11.65M 10-K · filed 2025-03-20 |
| 2023-09-30 | $15.29M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.89M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $4.45M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $8.94M 10-K · filed 2024-03-22 |
| 2022-09-30 | $2.68M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $4.77M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $6.99M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $9.61M 10-K · filed 2023-03-31 |
| 2021-09-30 | $11.43M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $5.47M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $5.38M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $2.66M 10-K · filed 2022-03-28 |
| 2020-09-30 | $4.35M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $225.96K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $671.36K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $1.99M 10-K · filed 2021-03-02 |
| 2019-09-30 | $1.72M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $3.08M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $4.72M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $1.95M 10-K · filed 2020-03-23 |
| 2018-09-30 | $1.16M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $2.04M 10-Q · filed 2018-08-10 |
| 2018-03-31 | $3.16M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $555.81K 10-K · filed 2019-03-14 |
| 2017-09-30 | $306.07K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $445.03K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $575.95K 10-Q · filed 2017-05-12 |
| 2016-12-31 | $279.49K 10-K · filed 2018-03-19 |
| 2016-09-30 | $635.25K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.02M 10-Q · filed 2016-08-12 |
| 2016-03-31 | $2.28M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $3.45M 10-K · filed 2017-03-10 |
| 2015-09-30 | $4.51M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $785.47K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $431.09K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $308.40K 10-K · filed 2016-03-21 |
| 2014-09-30 | $1.10M 10-Q · filed 2014-11-14 |
| 2014-07-31 | $78.59K 10-Q · filed 2014-09-15 |
| 2014-04-30 | $87.92K 10-Q · filed 2014-06-05 |
| 2014-01-31 | $103.65K 10-Q · filed 2014-03-17 |
| 2013-10-31 | $106.13K 10-Q · filed 2014-09-15 |
| 2013-07-31 | $87.06K 10-Q · filed 2013-09-16 |
| 2013-04-30 | $64.90K 10-Q · filed 2013-06-27 |
| 2012-10-31 | $38.35K 10-K · filed 2014-01-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |